EGFR and neoplasm: Through high-resolution single-cell analysis, scRNA-seq is able to comprehensively explore the dynamic changes of tumor cells and their microenvironment, reveal drug resistance-related cell subpopulations and their molecular features, and identify drug resistance biomarkers, thus helping us to gain a deeper understanding of the multidimensional mechanisms of EGFR-TKI resistance (Figure 2).